Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease

Thyroid

Autoimmune thyroid disease and thyroid function test fluctuations in patients with resistance to thyroid hormone

Eur J Endocrinol

Okazaki-Hada M, Nishihara E, Hisakado M, Kudo T, Ito M, Fukata S, Nishikawa M, Akamizu T, Miyauchi A

doi: 10.1530/EJE-21-0584

COMMENTED

Thyroid

Differences in Diagnostic Criteria Mask the True Prevalence of Thyroid Disease in Pregnancy - A Systematic Review and Meta-Analysis

Thyroid.

Dong A, Stagnaro-Green A

doi: 10.1089/thy.2018.0475.

COMMENTED

Thyroid

Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial

Lancet Diabetes Endocrinol.

Dehbi HM, Mallick U, Wadsley J, Newbold K, Harmer C, Hackshaw A

doi: 10.1016/S2213-

Obesity and Bariatric Surgery

Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: The ATTICA cohort study

Metabolism.

Kouvari M, Panagiotakos DB, Yannakoulia M, Georgousopoulou E, Critselis E, Chrysohoou C, Tousoulis D, Pitsavos C; ATTICA Study Investigators

doi: 10.1016/

Thyroid

Comparative approaches to understanding thyroid hormone regulation of neurogenesis

Mol Cell Endocrinol.

Gothié JD, Demeneix B, Remaud S

doi: 10.1016/j.mce.2017.05.020.

Type 2 DiabetesObesity and Bariatric Surgery

Contribution of endogenous glucagon-like Peptide-1 to changes in glucose metabolism and islet function in people with type 2 diabetes four weeks after roux-en-Y gastric bypass (RYGB)

Metabolism.

Shah M, Laurenti MC, Man CD, Ma J, Cobelli C, Rizza RA, Vella A

doi: 10.1016/j.metabol.2018.12.005.

Diabetes - GeneralGlycemic Control

Dissociation Between Hormonal Counterregulatory Responses and Cerebral Glucose Metabolism During Hypoglycemia

Diabetes.

Lee JJ, Khoury N, Shackleford AM, Nelson S, Herrera H, Antenor-Dorsey JA, Semenkovich K, Shimony JS, Powers WJ, Cryer PE, Arbeláez AM

doi: 10.2337/db17-0574.

COMMENTED

Thyroid

CD5L constitutes a novel biomarker for integrated hepatic thyroid hormone action

★ 1 Recommended and commented by Prof. emer. Dr Ulrich Keller, Faculty Member

doi: 10.1089/thy.2019.0635.

COMMENTED

Thyroid

Teprotumumab for the Treatment of Active Thyroid Eye Disease

★ 0 Recommended and commented by Prof. emer. Dr Ulrich Keller, Faculty Member

N Engl J Med.

Douglas RS, Kahaly GJ, Patel A, Sile S, Thompson EHZ, Perdok R, Fleming JC, Fowler BT, Marcocci C, Marinò M, Antonelli A, Dailey R, Harris GJ, Eckstein A, Schiffman J, Tang R, Nelson C, Salvi M, Wester S, Sherman JW, Vescio T, Holt RJ, Smith TJ

doi: 10.1056/NEJMoa1910434.

Related content

Autoimmune thyroid disease and thyroid function test fluctuations in patients with resistance to thyroid hormone

Differences in Diagnostic Criteria Mask the True Prevalence of Thyroid Disease in Pregnancy - A Systematic Review and Meta-Analysis

Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial

Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: The ATTICA cohort study

Comparative approaches to understanding thyroid hormone regulation of neurogenesis

Contribution of endogenous glucagon-like Peptide-1 to changes in glucose metabolism and islet function in people with type 2 diabetes four weeks after roux-en-Y gastric bypass (RYGB)

Dissociation Between Hormonal Counterregulatory Responses and Cerebral Glucose Metabolism During Hypoglycemia

CD5L constitutes a novel biomarker for integrated hepatic thyroid hormone action

Teprotumumab for the Treatment of Active Thyroid Eye Disease